OMER Q4 2020 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena

OMEROmeros Corporation

$835M

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$11M-68.2% YoY

Gross Profit

$11M99.2% margin

Operating Income

-$34M-318.1% margin

Net Income

-$37M-350.6% margin

EPS (Diluted)

$-0.60

QoQ Revenue Growth

-59.3%

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$18M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$181M

Total Liabilities

$302M

Stockholders' Equity

-$121M

Cash & Equivalents

$11M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11M	$33M	-68.2%
Gross Profit	$11M	$33M	-68.1%
Operating Income	-$34M	-$24M	-42.6%
Net Income	-$37M	-$29M	-27.5%